Company Filing History:
Years Active: 2014-2016
Title: Brian Lestini: Innovator in Combination Therapy
Introduction
Brian Lestini is a notable inventor based in Union City, NJ (US). He has made significant contributions to the field of medicine, particularly in the development of combination therapies for treating proliferative disorders. With a total of 2 patents, Lestini's work focuses on innovative approaches to combat serious health conditions.
Latest Patents
Lestini's latest patents include a groundbreaking combination therapy for proliferative disorders. The first patent relates to a combination of propane-1-sulfonic acid and an interferon, specifically peginterferon alfa-2a, aimed at treating patients with solid tumors such as colorectal cancer, melanoma, and thyroid cancer. This therapy is particularly effective for melanoma containing the V600E b-Raf mutation. The second patent also involves a combination therapy of propane-1-sulfonic acid, but this time paired with an EGFR inhibitor, targeting similar solid tumors.
Career Highlights
Throughout his career, Brian Lestini has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in developing innovative therapies.
Collaborations
Lestini has collaborated with notable professionals in the field, including Kapil Dhingra and Brian Higgins. These partnerships have enhanced his research and development efforts, leading to significant advancements in combination therapies.
Conclusion
Brian Lestini's contributions to the field of medicine through his innovative patents and collaborations highlight his commitment to improving treatment options for patients with proliferative disorders. His work continues to pave the way for advancements in medical therapies.